Weight-Loss Drug Obstacles; Bank Failure Fallout

In this week’s Bloomberg podcast, Bloomberg Intelligence analysts discuss the findings and impacts of their research:

Novo, Lilly Obesity-Drug Hurdles Include Cost, Cover: BI Survey -- Michael Shah explores a survey of doctors on the issues for prescribing weight-loss drugs. 

Regional Banks' Office Loans Gain More Urgency But a Longer Act -- Herman Chan lays out the developing concerns with real estate loans.

SVB's Failure May Mean $500 Billion Haircut for Venture Capital and Upending the Yale Endowment Model? -- Gaurav Patankar explains the impacts on venture capital, private equity and endowments.     

Too Much Skin in the Game? Equity May Create Perverse Incentives -- Rob Du Boff explains a negative side of equity-based pay.

Visa, Mastercard Balance Sheet Strength to Shine Amid SVB Chaos -- Diksha Gera looks at fintech liquidity and operating performance.

The Bloomberg Intelligence radio show with Paul Sweeney and Alix Steel podcasts through Apple’s iTunes, Spotify and Luminary. It broadcasts on Saturdays and Sundays at noon on Bloomberg’s flagship station WBBR (1130 AM) in New York, 106.1 FM/1330 AM in Boston, 99.1 FM in Washington, 960 AM in the San Francisco area, channel 119 on SiriusXM, www.bloombergradio.com, and iPhone and Android mobile apps.

Bloomberg Intelligence, the research arm of Bloomberg L.P., has more than 400 professionals who provide in-depth analysis on more than 2,000 companies and 135 industries while considering strategic, equity and credit perspectives. BI also provides interactive data from over 500 independent contributors. It is available exclusively for Bloomberg Terminal subscribers. See omnystudio.com/listener for privacy information.